搜索临床试验以:PD-1 inhibitor, bevacizumab
总计6900个结果
-
Symphogen A/S主动,不招人
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central Hospital撤销
-
Shanghai Junshi Bioscience Co., Ltd.未知
-
Providence Health & ServicesMerck Sharp & Dohme LLC; Providence Cancer Center, Earle A. Chiles Research Institute主动,不招人
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
The Fourth Affiliated Hospital of Zhejiang University...招聘中
-
Peking University招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 转移性乳腺癌美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 难治性恶性实体瘤 | KRAS基因突变 | 转移性恶性实体瘤 | 表皮生长因子受体基因突变 | ERBB2基因扩增 | ERBB2基因突变 | EGFR基因扩增 | ERBB3基因突变 | ERBB4基因突变美国
-
Shanghai Junshi Bioscience Co., Ltd.Iqvia Pty Ltd; TopAlliance Biosciences, Inc.主动,不招人
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.; Shanghai Junshi Bioscience Co., Ltd.招聘中
-
LiuYing尚未招聘大肠癌 | 新辅助治疗 | 错配修复缺陷 (dMMR) | 微卫星高不稳定性 (MSI-H)中国
-
Sichuan Cancer Hospital and Research Institute尚未招聘
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); AnYxis Immuno-Oncology GmbH; Provenance Biopharmaceuticals暂停
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central Hospital撤销
-
Sun Yat-sen UniversityChipscreen Biosciences, Ltd.尚未招聘复发或难治性 DLBCL
-
RenJi HospitalShanghai Zhongshan Hospital; Ruijin Hospital招聘中
-
Peking University Cancer Hospital & Institute招聘中
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...尚未招聘
-
University of PennsylvaniaParker Institute for Cancer Immunotherapy; Tmunity Therapeutics终止
-
Sun Yat-sen University招聘中
-
H. Lee Moffitt Cancer Center and Research Institute撤销
-
Fifth Affiliated Hospital, Sun Yat-Sen University招聘中
-
Sun Yat-sen UniversityChongqing University Cancer Hospital; Xiangya Hospital of Central South University; Tongji Hospital 和其他合作者招聘中
-
National Cancer Institute (NCI)完全的慢性粒单核细胞白血病 | 复发性成人急性髓性白血病 | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 先前治疗过的骨髓增生异常综合征 | 复发性成人急性淋巴细胞白血病 | 复发性慢性粒细胞白血病 | 继发性骨髓增生异常综合征 | 成人急性髓性白血病伴 t(15;17)(q22;q12) | 新生骨髓增生异常综合征 | 难治性贫血伴原始细胞过多 | 急变期慢性粒细胞白血病 | 转化中原始细胞过多的难治性贫血美国
-
Women's Hospital School Of Medicine Zhejiang University招聘中
-
Huazhong University of Science and Technology主动,不招人
-
Jiangsu Cancer Institute & Hospital主动,不招人
-
RenJi HospitalThe First Affiliated Hospital with Nanjing Medical University; Peking University First Hospital 和其他合作者招聘中
-
Tianjin Medical University Second HospitalCSPC Pharmaceutical Group Limited未知
-
Fondazione Policlinico Universitario Agostino Gemelli...招聘中黑色素瘤 | 肾癌 | 乳腺癌 | 胃癌 | 肺癌 | 膀胱癌 | 皮肤癌 | 头颈癌意大利
-
Memorial Sloan Kettering Cancer Center招聘中
-
Tianjin Medical University Cancer Institute and...招聘中